Healthcare - Biotechnology - NASDAQ - NL
$ 3.82
-3.29 %
$ 394 M
Market Cap
-12.32
P/E
Price Target
Average
--10.99%
Revenue Forecast
Estimate
96.54%
EBIT
Estimate
--16.32%
Net Income
Estimate
47.78%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ProQR Therapeutics N.V.
Wall Street analysts predict an average 1-year price target for PRQR of $3.4 , with forecasts ranging from a low of $2 to a high of $5 .
PRQR Lowest Price Target
Wall Street Target
2 USD
-47.64%
PRQR Average Price Target
Wall Street Target
3.4 USD
-10.99%
PRQR Highest Price Target
Wall Street Target
5 USD
30.89%
REVENUE FORECAST
Revenue Forecast Chart PRQR
EBIT FORECAST
EBIT Forecast Chart PRQR
NET INCOME FORECAST
Net Income Chart PRQR